ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · IEX Real-Time Price · USD
14.87
+0.03 (0.20%)
At close: Jun 18, 2024, 4:00 PM
15.19
+0.32 (2.15%)
After-hours: Jun 18, 2024, 6:05 PM EDT

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $813.81M in the twelve months ending March 31, 2024, with 56.43% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $205.83M with 73.75% year-over-year growth. In the year 2023, ACADIA Pharmaceuticals had annual revenue of $726.44M with 40.45% growth.

Revenue (ttm)
$813.81M
Revenue Growth
+56.43%
P/S Ratio
3.00
Revenue / Employee
$1,360,880
Employees
598
Market Cap
2.46B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023726.44M209.20M40.45%
Dec 31, 2022517.24M33.09M6.83%
Dec 31, 2021484.15M42.39M9.60%
Dec 31, 2020441.76M102.68M30.28%
Dec 31, 2019339.08M115.27M51.50%
Dec 31, 2018223.81M98.91M79.19%
Dec 31, 2017124.90M107.57M620.68%
Dec 31, 201617.33M17.27M28,311.48%
Dec 31, 201561.00K-59.00K-49.17%
Dec 31, 2014120.00K-1.03M-89.52%
Dec 31, 20131.15M-3.76M-76.67%
Dec 31, 20124.91M2.84M137.40%
Dec 31, 20112.07M-40.07M-95.09%
Dec 31, 201042.14M35.74M558.46%
Dec 31, 20096.40M4.81M302.45%
Dec 31, 20081.59M-5.97M-78.95%
Dec 31, 20077.56M-578.00K-7.11%
Dec 31, 20068.13M-2.82M-25.77%
Dec 31, 200510.96M6.35M137.97%
Dec 31, 20044.60M-2.77M-37.60%
Dec 31, 20037.38M1.10M17.57%
Dec 31, 20026.28M2.56M68.98%
Dec 31, 20013.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 2.86B
Evolent Health 2.18B
Progyny 1.11B
10x Genomics 625.45M
Certara 360.69M
TG Therapeutics 289.33M
ADMA Biologics 283.18M
Intellia Therapeutics 52.60M
Revenue Rankings